xamoterol has been researched along with emetine in 1 studies
Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (emetine) | Trials (emetine) | Recent Studies (post-2010) (emetine) |
---|---|---|---|---|---|
269 | 80 | 17 | 1,797 | 24 | 162 |
Protein | Taxonomy | xamoterol (IC50) | emetine (IC50) |
---|---|---|---|
Glucose transporter | Leishmania mexicana | 0.081 | |
Serine hydrolase RBBP9 | Homo sapiens (human) | 7.8 | |
Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.09 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 7.0667 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.038 | |
Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.108 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.182 | |
Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.0965 | |
Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 0.0965 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for xamoterol and emetine
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |